Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Herpesviridae Infections”

2,379 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,379 results

Early research (Phase 1)Study completedNCT00886613
What this trial is testing

Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)UnknownNCT00005959
What this trial is testing

Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Amgen
Testing effectiveness (Phase 2)WithdrawnNCT02973191
What this trial is testing

Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Celgene
Not applicableLooking for participantsNCT07361796
What this trial is testing

The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster

Who this might be right for
Herpes ZosterPainPostherpetic Neuralgia
Beijing Tiantan Hospital 832
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808610
What this trial is testing

Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRecurrent T Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia+1 more
M.D. Anderson Cancer Center 50
Large-scale testing (Phase 3)Ended earlyNCT00122525
What this trial is testing

Effect of Male Circumcision on HIV Incidence (ANRS 1265)

Who this might be right for
HIV InfectionsHerpes GenitalisVenereal Diseases
French National Agency for Research on AIDS and Viral Hepatitis 3,274
Not applicableStudy completedNCT00001648
What this trial is testing

Structure of the Herpes Simplex Virus Receptor

Who this might be right for
EncephalitisHerpes SimplexKeratitis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT03300882
What this trial is testing

PREDICT Cytomegalovirus (CMV)

Who this might be right for
Lung Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 84
Early research (Phase 1)Study completedNCT02223351
What this trial is testing

Drug-Drug Interaction Study: ASP2151 and Ritonavir

Who this might be right for
Healthy
Maruho Europe Limited 48
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Testing effectiveness (Phase 2)Temporarily pausedNCT06761677
What this trial is testing

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Lymphoma Including ENKL
SymBio Pharmaceuticals 43
Early research (Phase 1)Study completedNCT02924402
What this trial is testing

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

Who this might be right for
B-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Xencor, Inc. 154
Early research (Phase 1)Active Not RecruitingNCT03962465
What this trial is testing

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
University of Virginia 36
Post-approval studies (Phase 4)Study completedNCT02943057
What this trial is testing

Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis

Who this might be right for
Cytomegalovirus Infections
Singapore National Eye Centre 25
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Not applicableLooking for participantsNCT06375122
What this trial is testing

Natural History Study of Kaposi Sarcoma

Who this might be right for
Kaposi SarcomaHIV
National Cancer Institute (NCI) 150
Not applicableLooking for participantsNCT07422337
What this trial is testing

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

Who this might be right for
B-Cell ALLB-Cell Acute Lymphoblastic LeukaemiaB-Cell Lymphoblastic Leukemia+5 more
Arkansas Children's Hospital Research Institute 300
Early research (Phase 1)Looking for participantsNCT06927466
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.

Who this might be right for
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. 33
Post-approval studies (Phase 4)Study completedNCT02958345
What this trial is testing

Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

Who this might be right for
Herpes ZosterFibrosis
Tulane University 28
Load More Results